BOEING CO/THE (1BA.MI) Stock Fundamental Analysis
BIT:1BA - Euronext Milan - US0970231058 - Common Stock - Currency: EUR
We assign a fundamental rating of 1 out of 10 to 1BA. 1BA was compared to 40 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of 1BA have multiple concerns. 1BA does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year 1BA has reported negative net income.
1BA had a negative operating cash flow in the past year.
1BA had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: 1BA reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -7.59%, 1BA is doing worse than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.59% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for 1BA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
1BA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1BA has been increased compared to 1 year ago.
Compared to 5 years ago, 1BA has more shares outstanding
The debt/assets ratio for 1BA has been reduced compared to a year ago.
2.2 Solvency
1BA has an Altman-Z score of 1.02. This is a bad value and indicates that 1BA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.02, 1BA is doing worse than 77.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.02 |
ROIC/WACCN/A
WACC9.14%
2.3 Liquidity
1BA has a Current Ratio of 1.32. This is a normal value and indicates that 1BA is financially healthy and should not expect problems in meeting its short term obligations.
1BA's Current ratio of 1.32 is fine compared to the rest of the industry. 1BA outperforms 72.50% of its industry peers.
1BA has a Quick Ratio of 1.32. This is a bad value and indicates that 1BA is not financially healthy enough and could expect problems in meeting its short term obligations.
1BA's Quick ratio of 0.42 is on the low side compared to the rest of the industry. 1BA is outperformed by 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.42 |
3. Growth
3.1 Past
The earnings per share for 1BA have decreased strongly by -250.00% in the last year.
Looking at the last year, 1BA shows a very negative growth in Revenue. The Revenue has decreased by -14.50% in the last year.
The Revenue has been decreasing by -4.74% on average over the past years.
EPS 1Y (TTM)-250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1155.32%
Revenue 1Y (TTM)-14.5%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%-30.77%
3.2 Future
The Earnings Per Share is expected to grow by 18.96% on average over the next years. This is quite good.
The Revenue is expected to grow by 13.88% on average over the next years. This is quite good.
EPS Next Y90.79%
EPS Next 2Y47.89%
EPS Next 3Y32.88%
EPS Next 5Y18.96%
Revenue Next Year25.47%
Revenue Next 2Y20.66%
Revenue Next 3Y17.16%
Revenue Next 5Y13.88%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for 1BA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 1BA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as 1BA's earnings are expected to grow with 32.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.89%
EPS Next 3Y32.88%
5. Dividend
5.1 Amount
1BA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1BA (4/22/2025, 7:00:00 PM)
140.34
+1.1 (+0.79%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners75.41%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap105.59B
Analysts78.33
Price Target187.62 (33.69%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.7%
Min EPS beat(2)-91.07%
Max EPS beat(2)3.66%
EPS beat(4)2
Avg EPS beat(4)-23.11%
Min EPS beat(4)-91.07%
Max EPS beat(4)37.77%
EPS beat(8)4
Avg EPS beat(8)-7.22%
EPS beat(12)4
Avg EPS beat(12)-872.64%
EPS beat(16)5
Avg EPS beat(16)-763.86%
Revenue beat(2)0
Avg Revenue beat(2)-5.74%
Min Revenue beat(2)-8.71%
Max Revenue beat(2)-2.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.33%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)-0.87%
Revenue beat(8)2
Avg Revenue beat(8)-1.93%
Revenue beat(12)2
Avg Revenue beat(12)-4.68%
Revenue beat(16)2
Avg Revenue beat(16)-5.02%
PT rev (1m)-3.8%
PT rev (3m)3.05%
EPS NQ rev (1m)-31.82%
EPS NQ rev (3m)-217.36%
EPS NY rev (1m)-20.53%
EPS NY rev (3m)-966%
Revenue NQ rev (1m)-0.72%
Revenue NQ rev (3m)-0.8%
Revenue NY rev (1m)0.51%
Revenue NY rev (3m)-0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.81 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-17.84
EYN/A
EPS(NY)-1.64
Fwd EYN/A
FCF(TTM)-16.76
FCFYN/A
OCF(TTM)-14.06
OCFYN/A
SpS77.45
BVpS-4.55
TBVpS-16.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.59% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 126.25% | ||
| Cap/Sales | 3.48% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.42 | ||
| Altman-Z | 1.02 |
F-Score2
WACC9.14%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1155.32%
EPS Next Y90.79%
EPS Next 2Y47.89%
EPS Next 3Y32.88%
EPS Next 5Y18.96%
Revenue 1Y (TTM)-14.5%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%-30.77%
Revenue Next Year25.47%
Revenue Next 2Y20.66%
Revenue Next 3Y17.16%
Revenue Next 5Y13.88%
EBIT growth 1Y-1218.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.92%
EBIT Next 3Y50.05%
EBIT Next 5Y32.37%
FCF growth 1Y-424.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-302.68%
OCF growth 3YN/A
OCF growth 5YN/A